[go: up one dir, main page]

BR0202358A - Stretch Mark Gel - Google Patents

Stretch Mark Gel

Info

Publication number
BR0202358A
BR0202358A BR0202358A BR0202358A BR0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A BR 0202358 A BR0202358 A BR 0202358A
Authority
BR
Brazil
Prior art keywords
gel
addition
apply
bovine bile
substances
Prior art date
Application number
BR0202358A
Other languages
Portuguese (pt)
Inventor
Eneida Aparecida De Brito
Original Assignee
Eneida Aparecida De Brito
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eneida Aparecida De Brito filed Critical Eneida Aparecida De Brito
Priority to BR0202358A priority Critical patent/BR0202358A/en
Publication of BR0202358A publication Critical patent/BR0202358A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"GEL PARA TRATAMENTO DE ESTRIAS". Gel para tratamento de estrias, caracterizada por proporcionar significativo ganho estético com eficácia de maior duração. O referido gel contém em sua composição, além das substâncias comumente utilizadas para este tipo de produto, o extrato de bile bovina, que concentra as propriedades dos ácidos retinóico e glicólico e da vitamina C. Além destas, a bile bovina contém ainda as substâncias colesterol, bilirrubina e ácido cólico, que estimulam a produção de colágeno, responsável por uma eficácia que pode variar de 70% (setenta por cento) a 90% (noventa por cento) na redução das estrias. Modo de uso: aplicar quantidade generosa do gel no local afetado, espalhando uniformemente sobre a pele. Deixar agir por 30 (trinta) minutos e enxaguar abundantemente. Após, aplicar hidratante corporal. Não há contra-indicações."GEL FOR TREATMENT TREATMENT". Stretch mark gel, characterized by providing significant aesthetic gain with longer lasting efficacy. In addition to the substances commonly used for this type of product, this gel contains bovine bile extract, which concentrates the properties of retinoic and glycolic acids and vitamin C. In addition to these, bovine bile also contains cholesterol substances. , bilirubin and colic acid, which stimulate collagen production, responsible for an effectiveness that can range from 70% (seventy percent) to 90% (ninety percent) in reducing stretch marks. How to use: Apply generous amount of gel on the affected area, spreading evenly over the skin. Leave to act for 30 (thirty) minutes and rinse thoroughly. After, apply body moisturizer. There are no contraindications.

BR0202358A 2002-05-27 2002-05-27 Stretch Mark Gel BR0202358A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0202358A BR0202358A (en) 2002-05-27 2002-05-27 Stretch Mark Gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0202358A BR0202358A (en) 2002-05-27 2002-05-27 Stretch Mark Gel

Publications (1)

Publication Number Publication Date
BR0202358A true BR0202358A (en) 2004-05-04

Family

ID=32181103

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0202358A BR0202358A (en) 2002-05-27 2002-05-27 Stretch Mark Gel

Country Status (1)

Country Link
BR (1) BR0202358A (en)

Similar Documents

Publication Publication Date Title
BR0015604A (en) Method for the treatment of hypertrophic scars in order to reduce the size and / or improve their appearance, compositions to treat adverse skin conditions, and, to reduce the size and improve the appearance of hypertrophic scars
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
BR0309890A (en) Pharmaceutical composition containing blood plasma or blood serum used in the treatment of lesions, as well as its method and application process
ATE291433T1 (en) FEMALE EXTRACTS (TANACETUM PARTHENIUM) AGAINST INFLAMMATORY DISEASES
BR0013897A (en) Use of conjugated linoleic acid (cla) or a derivative thereof, topical cosmetic or dermatological composition, and method of treatment and / or prophylaxis of cellulite and fat deposits
BRPI0011640B8 (en) oligosaccharide aldonic acids and their topical use
BR0308799A (en) dha and rosemary co-globules and method of use
DE60313597D1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS
ES2190472T3 (en) TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN.
BR0312232A (en) Caspase inhibitors and their uses
ATE112684T1 (en) USE OF IGF-II TO TREAT BONE DISEASES.
ATE97316T1 (en) COSMETIC AGENT AND COMPOSITION FOR TREATMENT OF THE SKIN.
DK284386D0 (en) PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS
PT942741E (en) LECTIN COMPOSITIONS AND THEIR USES
BRPI0507895A (en) composition for the treatment of chronic venous insufficiency, comprising an extract of red vine leaves and an anti-inflammatory agent
BR0111506A (en) Macromolecular drug complexes and compositions containing same
HUP0304077A2 (en) Pharmaceutical and cosmetic compositions against skin aging
TR200100897T2 (en) Propanolamine derivatives bound with bile acids in the treatment of lipid metabolism disorders.
BR0202358A (en) Stretch Mark Gel
BR0109148A (en) Methods for increasing intestinal absorption of a fat-soluble vitamin in a postmenopausal woman, for increasing bile secretion of a fat-soluble vitamin in a postmenopausal woman, for increasing the liver concentration of a fat-soluble vitamin in a postmenopausal woman to reduce the risk of one or more diseases in a postmenopausal woman and to reduce the risk of one or more diseases in an animal
BRPI0417692A (en) use of a composition, method of reducing the effects of psychologically mediated stress on the skin of a human or animal, composition, nutritional supplement, cosmetic composition, and method for identifying a compound capable of reducing the effects and method of producing a composition. for reducing the effects of psychologically mediated stress on the skin of a human or animal
CN107308028A (en) Cutaneous penetration essence
US20140030365A1 (en) Compositions for the debridement, granulation and reepithelialization of wounds in man
AU2002312382B2 (en) Topical treatments using alkanolamines
BR0308517A (en) Combination of an aldosterone receptor antagonist and bile acid sequestering agent

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07A Technical examination (opinion): publication of technical examination (opinion)
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: PAGAR RESTAURACAO.

B08H Application fees: decision cancelled

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014.

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8 E 13 DA LPI

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.